Kosuke Asagoe, MD, PhD

Shiga General Hospital
Department of Hematology and Oncology
Shiga Japan Papers:
3305 Phase II Trial of Bortezomib-Based Induction, Autologous Stem Cell Transplantation, Bortezomib-Based Consolidation, and Bortezomib Maintenance in Newly Diagnosed Multiple Myeloma in Japan